{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:48:31Z","timestamp":1768902511958,"version":"3.49.0"},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,1]]},"DOI":"10.12788\/cutis.0366","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T20:12:01Z","timestamp":1636488721000},"source":"Crossref","is-referenced-by-count":2,"title":["Duration of Adalimumab Therapy in Hidradenitis Suppurativa With and Without Oral Immunosuppressants"],"prefix":"10.12788","volume":"108","author":[{"given":"Micaella","family":"Zubkov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","published-online":{"date-parts":[[2021,10,1]]},"container-title":["Cutis"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/issues\/articles\/ct108004199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T20:12:01Z","timestamp":1636488721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/dermatology\/article\/247311\/autoimmune-diseases\/duration-adalimumab-therapy-hidradenitis-suppurativa"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,9,1]]},"published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.12788\/cutis.0366","relation":{},"subject":[],"published":{"date-parts":[[2021,10,1]]}}}